Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
ABT-737 increases tyrosine kinase inhibitor-induced apoptosis in chronic myeloid leukemia cells through XIAP downregulation and sensitizes CD34(+) CD38(-) population to imatinib.
Airiau K, Mahon FX, Josselin M, Jeanneteau M, Turcq B, Belloc F.
Exp Hematol. 2012 May;40(5):367-78.e2. Epub 2012 Jan 10.
Related citations
Sonic hedgehog maintains survival and growth of chronic myeloid leukemia progenitor cells through β-catenin signaling.
Su W, Meng F, Huang L, Zheng M, Liu W, Sun H.
Exp Hematol. 2012 May;40(5):418-27. Epub 2012 Jan 10.
Chemosensitivity of nonleukemic clonogenic precursors in AML patients in complete remission: association with CD34(+) mobilization and with disease-free survival.
Milone G, Avola G, Leotta S, Strano A, Camuglia MG, Pinto V, Mercurio S, Poidomani M, Coppoletta S, Di Marco AL, Consoli C, Triolo A, Spadaro A, Privitera A, Ragusa A, Tibullo D, Di Mercurio S.
Exp Hematol. 2012 Jan;40(1):35-47.e2. Epub 2011 Oct 20.
HSPB8 is methylated in hematopoietic malignancies and overexpression of HSPB8 exhibits antileukemia effect.
Cui XY, Wang N, Yang BX, Gao WF, Lin YM, Yao XR, Ma XT.
Exp Hematol. 2012 Jan;40(1):14-21. Epub 2011 Sep 10.
A subset of chronic lymphocytic leukemia patients display reduced levels of PARP1 expression coupled with a defective irradiation-induced apoptosis.
Bacalini MG, Tavolaro S, Peragine N, Marinelli M, Santangelo S, Del Giudice I, Mauro FR, Di Maio V, Ricciardi MR, Caiafa P, Chiaretti S, Foà R, Guarini A, Reale A.
Exp Hematol. 2012 Mar;40(3):197-206.e1. doi: 10.1016/j.exphem.2011.11.005. Epub 2011 Nov 23.
Para-NO-aspirin inhibits NF-κB and induces apoptosis in B-cell progenitor acute lymphoblastic leukemia.
Khan NI, Cisterne A, Baraz R, Bradstock KF, Bendall LJ.
Exp Hematol. 2012 Mar;40(3):207-215.e1. doi: 10.1016/j.exphem.2011.11.001. Epub 2011 Nov 17.
LAK cell therapy of AML: not to be lost in translation.
Takei F.
Exp Hematol. 2011 Nov;39(11):1045-6. doi: 10.1016/j.exphem.2011.08.005. Epub 2011 Aug 23. Review.
Impact of the hypomethylating agent 5-azacytidine on dendritic cells function.
Frikeche J, Clavert A, Delaunay J, Brissot E, Grégoire M, Gaugler B, Mohty M.
Exp Hematol. 2011 Nov;39(11):1056-63. doi: 10.1016/j.exphem.2011.08.004. Epub 2011 Aug 18.
Nonviral transfection of leukemic primary cells and cells lines by siRNA-a direct comparison between Nucleofection and Accell delivery.
Larsen HØ, Roug AS, Nielsen K, Søndergaard CS, Hokland P.
Exp Hematol. 2011 Nov;39(11):1081-9. doi: 10.1016/j.exphem.2011.08.003. Epub 2011 Aug 18.
Heterogeneity of leukemia stem cell candidates at diagnosis of acute myeloid leukemia and their clinical significance.
Ran D, Schubert M, Taubert I, Eckstein V, Bellos F, Jauch A, Chen H, Bruckner T, Saffrich R, Wuchter P, Ho AD.
Exp Hematol. 2012 Feb;40(2):155-65.e1. Epub 2011 Oct 21.
Deciphering transcriptional control mechanisms in hematopoiesis:the impact of high-throughput sequencing technologies.
Wilson NK, Tijssen MR, Göttgens B.
Exp Hematol. 2011 Oct;39(10):961-8. doi: 10.1016/j.exphem.2011.07.005. Epub 2011 Jul 23. Review.
hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Borssén M, Cullman I, Norén-Nyström U, Sundström C, Porwit A, Forestier E, Roos G.
Exp Hematol. 2011 Dec;39(12):1144-51. doi: 10.1016/j.exphem.2011.08.014. Epub 2011 Sep 10.
A truncation mutant of Csf3r cooperates with PML-RARα to induce acute myeloid leukemia in mice.
Kunter G, Woloszynek JR, Link DC.
Exp Hematol. 2011 Dec;39(12):1136-43. doi: 10.1016/j.exphem.2011.08.013. Epub 2011 Sep 10.
CD45 regulates homing and engraftment of immature normal and leukemic human cells in transplanted immunodeficient mice.
Shivtiel S, Lapid K, Kalchenko V, Avigdor A, Goichberg P, Kalinkovich A, Nagler A, Kollet O, Lapidot T.
Exp Hematol. 2011 Dec;39(12):1161-1170.e1. doi: 10.1016/j.exphem.2011.08.012. Epub 2011 Sep 10.
Recurrence of monoclonal gammopathy associated with donor-derived myelodysplastic syndrome after cord blood stem cell transplantation.
Yamazaki R, Nakasone H, Wada H, Sakamoto K, Ashizawa M, Sato M, Terasako K, Kikuchi M, Kimura S, Okuda S, Kako S, Tanaka Y, Tanihara A, Oshima K, Nishida J, Kanda Y.
Exp Hematol. 2011 Dec;39(12):1119-23. doi: 10.1016/j.exphem.2011.09.002. Epub 2011 Sep 10.
Interleukin-15 enhances rituximab-dependent cytotoxicity against chronic lymphocytic leukemia cells and overcomes transforming growth factor beta-mediated immunosuppression.
Moga E, Cantó E, Vidal S, Juarez C, Sierra J, Briones J.
Exp Hematol. 2011 Nov;39(11):1064-71. doi: 10.1016/j.exphem.2011.08.006. Epub 2011 Aug 22.
miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.
Ovcharenko D, Stölzel F, Poitz D, Fierro F, Schaich M, Neubauer A, Kelnar K, Davison T, Müller-Tidow C, Thiede C, Bornhäuser M, Ehninger G, Brown D, Illmer T.
Exp Hematol. 2011 Oct;39(10):1030-1042.e7. doi: 10.1016/j.exphem.2011.07.008. Epub 2011 Jul 22.
The influence of pretransplantation conditioning on graft-vs.-leukemia effect in mice.
Lim JY, Choi MS, Youn H, Choi EY, Min CK.
Exp Hematol. 2011 Oct;39(10):1018-29. doi: 10.1016/j.exphem.2011.07.003. Epub 2011 Jul 20.
Clinical scale expansion of cytokine-induced killer cells is feasible from healthy donors and patients with acute and chronic myeloid leukemia at various stages of therapy.
Niam M, Linn YC, Fook Chong S, Lim TJ, Chu S, Choong A, Yong HX, Suck G, Chan M, Koh M.
Exp Hematol. 2011 Sep;39(9):897-903.e1. doi: 10.1016/j.exphem.2011.06.005. Epub 2011 Jun 16.
Liposomal encapsulation of a synergistic molar ratio of cytarabine and daunorubicin enhances selective toxicity for acute myeloid leukemia progenitors as compared to analogous normal hematopoietic cells.
Kim HP, Gerhard B, Harasym TO, Mayer LD, Hogge DE.
Exp Hematol. 2011 Jul;39(7):741-50. Epub 2011 Apr 9.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on